NeuroDawn Pharmaceutical Funding: $11M Raised, Series C
NeuroDawn Pharmaceutical is based in Nanjing, Jiangsu, China. It has raised $11M in total funding. Latest round: Series C.
NeuroDawn Pharmaceutical funding overview
NeuroDawn Pharmaceutical is based in Nanjing, Jiangsu, China. NeuroDawn Pharmaceutical has raised $11M in total disclosed funding. That places its disclosed total in the $1M–$25M range. Its most recent disclosed round is a Series C announced in November 2024. The round record for NeuroDawn Pharmaceutical runs through 2024; nothing later has been disclosed. Investors on record include Jiangning High-tech Zone and Science and Technology Venture…, Huaxing Kangping. 2 distinct backers are named across the disclosed rounds.
NeuroDawn Pharmaceutical at a glance
Total raised
$11M
Latest round
Series C
Latest round date
November 2024
Headquarters
Nanjing, Jiangsu, China
Notable investors
Jiangning High-tech Zone and Science and Technology Venture…, Huaxing Kangping
Frequently asked about NeuroDawn Pharmaceutical funding
How much has NeuroDawn Pharmaceutical raised?
NeuroDawn Pharmaceutical has raised $11M in total disclosed funding across the rounds on record.
Who has invested in NeuroDawn Pharmaceutical?
Jiangning High-tech Zone and Science and Technology Venture…, Huaxing Kangping are named among the investors backing NeuroDawn Pharmaceutical.
What was the latest NeuroDawn Pharmaceutical funding round?
The most recent disclosed round is a Series C, announced in November 2024.
Where is NeuroDawn Pharmaceutical based?
NeuroDawn Pharmaceutical is based in Nanjing, Jiangsu, China.
When did NeuroDawn Pharmaceutical last raise?
The last disclosed NeuroDawn Pharmaceutical round closed in November 2024 at Series C.
Every NeuroDawn Pharmaceutical figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Nanjing at a similar stage.
Companies related to NeuroDawn Pharmaceutical (18)
